Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / European Union — European Medicines Agency / European Union

European Union — European Medicines Agency & European Union

3 shared events · Importance 3 · Last updated Apr 29, 2026

Importance
3
Shared Events
3
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (3)
0
Business
Dupixent EU Recommendation, US Approval
European Union — European Medicines Agency: The European Union — European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of Dupixent for chronic spontaneous urticaria (CSU) in the European Union.
Feb 24, 2026 · 8 articles
0
Business
Dupixent Approved for Pediatric CSU in EU
Apr 13, 2026 · 8 articles
0
Tech
AlpE Tuberculosis Drug Data Published
Apr 13, 2026 · 7 articles
NEWSDESK
Explore this relationship live

Track how European Union — European Medicines Agency and European Union interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.